Principal Investigator
Gilberto Lopes
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20231319
Clinical Trial Summary
A Phase 1 Study Evaluating the Safety, Tolerability, and Efficacy of BL-B01D1 in Subjects With Metastatic or Unresectable Non-Small Cell Lung Cancer and Other Solid Tumors
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Thoracic Oncology
Contact Information
Phone Number
305-243-2647